SAN DIEGO, May 3, 2011 /PRNewswire/ — Althea Technologies, Inc.
announced today that they have entered into a commercial supply
agreement with Biotest Pharmaceuticals Corporation. Under the
terms of the agreement, Althea will fill commercial drug products
to supply the U.S. market. The products will be filled in
Althea’s new commercial manufacturing facility in San Diego.
“We are very pleased to be selected by Biotest as their
strategic partner and commercial filler,” stated Rick Hancock,
President, Althea Technologies. “We are looking forward to
supporting Biotest as their commercial manufacturing partner.”
About Althea Technologies, Inc.
Althea Technologies is a fully integrated, contract development
and manufacturing organization that provides services for plasmid
DNA, recombinant proteins, and sterile products. Located in San
Diego, CA, Althea offers cell banking, process development, cGMP
protein & plasmid production, analytical development,
formulation and lyophilization development, and aseptic filling in
vials & prefilled syringes for clinical development and
commercialization. Althea’s formulation technology platform
employs crystalomics that can be applied to a variety of peptides
and proteins for high concentration or sustained release
formulations. For more information, visit www.altheatech.com.